Vertex Pharmaceuticals Inc / Ma
VRTX
Revenue
2.65B
▼-45.00M▼-1.67%
3 Months ChangeAssets
20.13B
▼-3.79B▼-15.83%
3 Months ChangeLiabilities
5.36B
▼-13.40M▼-0.2495%
3 Months ChangeFree Cash Flow
1.24B
▲380.40M▲44.35%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-16
Form 8-K
ID: 0000875320-24-000207
2024-08-02
Form 10-Q
ID: 0000875320-24-000198
2024-08-01
Form 8-K
ID: 0000875320-24-000193
2024-06-27
Form 8-K
ID: 0000875320-24-000178
2024-05-20
Form 8-K
ID: 0001193125-24-142278
2024-05-15
Form 8-K
ID: 0000875320-24-000142
2024-05-07
Form 10-Q
ID: 0000875320-24-000139
2024-05-06
Form 8-K
ID: 0000875320-24-000137
2024-04-11
Form 8-K
ID: 0001193125-24-092475
2024-02-05
Form 8-K
ID: 0000875320-24-000012